Showing results (21-30 of 158) with videos related to
Sort By:
Pageof 16
ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of Pyrido[3',2':5,6]thiopyrano[4,3-d]pyrimidine-Based Antiproliferative Multikinase InhibitorsSilvia Salerno, Elisabetta Barresi, Aída Nelly García-Argáez, et al.European Journal of Medicinal Chemistry|May 11, 2021
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffoldSilvia Salerno, Giorgio Amendola, Andrea Angeli, et al.European Journal of Medicinal Chemistry|March 17, 2018
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitorsSilvia Salerno, Aída Nelly García-Argáez, Elisabetta Barresi, et al.Journal of Medicinal Chemistry|March 18, 2021
Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo ActivityValentina Albanese, Chiara Ruzza, Erika Marzola, et al.Current Topics in Medicinal Chemistry|December 30, 2011
From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affairBarbara Cosimelli, Sandro Cosconati, Luciana Marinelli, et al.Journal of Medicinal Chemistry|August 9, 2017
Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung CancerFloriana Morgillo, Giorgio Amendola, Carminia Maria Della Corte, et al.Journal of Chemical Information and Modeling|June 11, 2026
AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 BindersSaurabh Upadhyay, Michele Roggia, Shaoren Yuan, et al.Journal of Chemical Information and Modeling|May 19, 2026
PyRMD Studio: A Unified Suite for Next-Generation, AI-Powered Virtual ScreeningBenito Natale, Muhammad Waqas, Michele Roggia, et al.Biorxiv : the Preprint Server for Biology|April 3, 2026
AI-Enforced Ultra-Large Virtual Screening Discovers Potent CD28 BindersSaurabh Upadhyaya, Michele Roggia, Shaoren Yuan, et al.Journal of Medicinal Chemistry|August 2, 2017
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs)Santo Previti, Roberta Ettari, Sandro Cosconati, et al.Pageof 16